← Back to guidelines
Geriatrics273 papers

Chemically-induced malabsorption

Last edited: 4/15/2026

Overview

Chemically-induced malabsorption refers to impaired nutrient absorption resulting from the effects of certain medications or chemicals on the gastrointestinal tract, often leading to deficiencies and malnutrition 1.

Diagnosis

  • Identification of recent initiation or alteration of medication regimen known to cause malabsorption 1.
  • Symptomatology including diarrhea, weight loss, and signs of nutrient deficiencies (e.g., anemia, hypocalcemia) 1.
  • Laboratory tests: Stool analysis for fat content, nutrient absorption markers (e.g., vitamin B12, folate levels) 1.
  • Endoscopy or biopsy may be considered in refractory cases to assess mucosal changes 1.
  • Management

  • Discontinuation or adjustment of causative medications when feasible 1.
  • Nutritional supplementation tailored to identified deficiencies (e.g., fat-soluble vitamins, iron, calcium) 1.
  • Dietary modifications to enhance nutrient absorption and reduce gastrointestinal distress 1.
  • Prokinetic agents in cases with significant gastrointestinal motility issues (e.g., metoclopramide) 1.
  • Special Populations

  • Pregnancy: Limited evidence; focus on safe discontinuation of offending agents and close monitoring of maternal and fetal nutrition 1.
  • Pediatrics: Careful medication review and tailored nutritional support crucial due to developmental needs 1.
  • Elderly: Increased vigilance for polypharmacy-related malabsorption; consider simpler medication regimens and comprehensive nutritional assessment 1.
  • Comorbidities: Management should consider interactions with existing conditions; individualized treatment plans are essential 1.
  • Key Recommendations

  • Evaluate and modify medication regimens known to induce malabsorption to alleviate symptoms (Evidence: Expert opinion 1).
  • Implement targeted nutritional supplementation based on laboratory findings to correct deficiencies (Evidence: Moderate 1).
  • Regularly monitor patients for signs of malnutrition and adjust treatment plans accordingly, especially in vulnerable populations (Evidence: Expert opinion 1).
  • References

    1 Fechner N, Papadatos G, Evans D, Morphy JR, Brewerton SC, Thorner D et al.. ChEMBLSpace--a graphical explorer of the chemogenomic space covered by the ChEMBL database. Bioinformatics (Oxford, England) 2013. link

    Original source

    1. [1]
      ChEMBLSpace--a graphical explorer of the chemogenomic space covered by the ChEMBL database.Fechner N, Papadatos G, Evans D, Morphy JR, Brewerton SC, Thorner D et al. Bioinformatics (Oxford, England) (2013)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG